Preclinical • Combination therapy • PARP Biomarker • IO biomarker
|
FLT3 (Fms-related tyrosine kinase 3) • CASP3 (Caspase 3)
|
FLT3-ITD mutation • FLT3 mutation • FLT3 D835Y • FLT3 F691L • FLT3 D835 • MCL1 expression
|
Venclexta (venetoclax) • sorafenib • Rydapt (midostaurin) • Vanflyta (quizartinib) • S63845 • MIK665